Full Text
Full text is available in PDF
Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients
Authors
1Department of Medicine III,RWTH-University Hospital Aachen, frank.tacke@gmx.net, Germany
*Corresponding Author: Department of Medicine III,RWTH-University Hospital Aachen, frank.tacke@gmx.net, Germany. Tel: +49 241 80 35848. Fax: +49 241 80 82455. Email: frank.tacke@gmx.net
Published online:Sep 30, 2010
Article type:Letter
Received:Apr 13, 2010
Accepted:Apr 15, 2010
How to Cite:Tacke F. Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients. Hepat Mon. 2010;10(3):. doi:
Abstract
This article does not have abstract.
KeywordsArticle
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Sep
2010
Efficacy of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV: Interpretation of Results and Future Prospects
Hossein Khedmat
Khedmat H. Efficacy of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV: Interpretation of Results and Future Prospects. Hepat Mon. 2010;10(3):. doi:
22
Nov
2014
Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
Mohamad Amin Pourhoseingholi,
Sara Ashtari,
Seyed Moayed Alavian
Pourhoseingholi MA, Ashtari S, Alavian SM. Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?. Hepat Mon. 2014;14(11):25540. doi: https://doi.org/10.5812/hepatmon.25540
30
Jun
2010
The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis
Seyed Moayed Alavian,
Bita Behnava,
Seyed Vahid Tabatabaei
Alavian S, Behnava B, Tabatabaei S. The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis. Hepat Mon. 2010;10(2):. doi:
30
Sep
2010
Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives
Valli De Re
Re V. Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives. Hepat Mon. 2010;10(3):. doi:
30
Sep
2004
Optimal Therapy for Hepatitis C
Seyed Moayed Alavian
Alavian S. Optimal Therapy for Hepatitis C. Hepat Mon. 2004;4(7):. doi:
Cited by
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 0
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 10 hours ago
- OpenAlex: 0
Last Update: 1 day ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0